Skip to main content
Thermo Fisher Scientific Inc.
Healthcare · Diagnostics & Research
Made on Aug 3, 2026
Price at call $574.30
6-month call Bear -6.8%
Target by Feb 2027 $535.00
Great value below $430.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -6.8% to $535.00
Predicted High $585.00 at 1 month
Predicted Low $535.00 at 6 months
Max Drawdown (predicted) -6.8%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 3, 2026 12:36 am
Bear TMO trends lower to $535.00 (-6.8% from $574.30) by Feb 2027. ride-then-fade
ThesisTMO's platform-monopoly narrative and post-earnings analyst upgrades create near-term upward drift despite rich valuation. With no earnings catalyst in window and low beta, momentum likely persists for weeks before value gravity slowly reasserts, producing a mild ride-then-fade toward the deterministic baseline.
Invalidated ifA break below $520 on rising volume, or a hawkish macro shift pushing regime risk-off, would invalidate the near-term drift-up.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $574.30 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 3, 2026 $574.30 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 17, 2026 $535.49–$613.11 typical range · internal point $580.50 ±6.8% 6/10 Post-earnings momentum and analyst upgrades extend near-term
What actually happened: closed $588.29 on Aug 14, 2026 = +2.4% vs the call (predicted +1.1%)  ·  direction HIT (called flat, was flat)  ·  off by 1.4 pp  ·  accuracy 10/10  ·  typical range ±6.8%: inside the band  ·  S&P +2.4% over the same window — lagged it
1 month Sep 3, 2026 $518.06–$630.54 typical range · internal point $585.00 ±9.8% 5/10 Narrative strength continues, low beta dampens moves
2 months Oct 3, 2026 $578.00 +0.6% 4/10 Momentum plateaus as valuation stretch draws scrutiny
3 months Nov 3, 2026 $565.00 -1.6% 4/10 Mild fade begins as sentiment normalizes
4 months Dec 3, 2026 $555.00 -3.4% 4/10 Value gravity pulls toward anchored-PE zone
5 months Jan 3, 2027 $545.00 -5.1% 3/10 Rate-heavy backdrop weighs on premium multiples
6 months Feb 3, 2027 $535.00 -6.8% 3/10 Converges near deterministic baseline endpoint

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $530.81 (-7.6%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 1 degraded · 0 notes — follow the chain top-down (cause → effect).
  • Degraded
    [warning] Valuation is extremely fragile — almost no scenarios support the current price
    upstream:valuation-synthesis

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$574.30
Composite fair value$330.11
Signal-adjusted fair value$319.94
DCF fair value$276.96
Anchored-PE fair value$555.42
Buy-below (value lens)$430.00
Value net score-68
Value confidence6 / 10
Quality net score+43
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 34.6%  3m 33.9%  6m 34.1%  
Daily σ (realism noise)2.1%
Beta vs S&P 500 1m -0.56  3m 0.10  5m 0.61  
Trailing 6-month return-3.0%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 3, 2026 freshest TMO-20260803-000636-8625
ext-forensic-memo Aug 3, 2026 freshest ext-TMO-20260803-002617-9bfe
ext-lens-quality Aug 3, 2026 freshest ext-TMO-20260803-002617-9bfe
ext-lens-sentiment Aug 3, 2026 freshest ext-TMO-20260803-002617-9bfe
ext-lens-value Aug 3, 2026 freshest ext-TMO-20260803-002617-9bfe
scenario-valuation Aug 3, 2026 freshest TMO-20260803-000636-8625
valuation-synthesis Aug 3, 2026 freshest TMO-20260803-000636-8625

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 3, 2026 v0.6.0 Bear $574.30 $535.00 -6.8% Feb 2027 viewing
Jun 28, 2026 v0.3.0 Bear $513.03 $471.39 -8.1% Dec 2026 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.